Scholarlink

<p>Porcine epidemic diarrhea virus (PEDV) causes severe mortality in piglets, inflicting significant economic losses globally. Nanobodies (Nbs) offer distinct advantages over conventional antibodies for disease intervention. This study aimed to develop neutralizing Nbs against the PEDV spike (S) protein. We constructed a eukaryotic plasmid encoding the S protein of the CH-HB2-2018 strain and expressed it in HEK-293&#xa0;F cells. Following alpaca immunization with the purified S protein, a phage display library was constructed. Biopanning yielded 70 unique Nbs based on CDR diversity, with 67 confirmed as specific binders via ELISA and Western blot. Further characterization using immunofluorescence and flow cytometry identified 9 specific candidates. Microneutralization assays revealed that these candidates showed varying degrees of inhibition against PEDV replication in Vero cells. Notably, nanobody 3Nb17 exhibited the highest binding affinity and neutralizing titer. These findings highlight 3Nb17 as a promising candidate for developing novel PEDV diagnostic tools and therapeutics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Neutralizing nanobodies against porcine epidemic diarrhea virus: discovery and characterization

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月23日

查看全文
  • Mengya Fan,
  • Xuran Wang,
  • Yangyang Yan,
  • Lili Wang,
  • Jiayi Wei,
  • Guohu Chen,
  • Yufei Wang,
  • Junlan Zan,
  • Lianping Xu,
  • Fengsai Li,
  • Shijie Yan,
  • Shanshan Yang,
  • Ping Rui,
  • Zengjun Ma,
  • Wei Liu,
  • Tao Song

摘要

Porcine epidemic diarrhea virus (PEDV) causes severe mortality in piglets, inflicting significant economic losses globally. Nanobodies (Nbs) offer distinct advantages over conventional antibodies for disease intervention. This study aimed to develop neutralizing Nbs against the PEDV spike (S) protein. We constructed a eukaryotic plasmid encoding the S protein of the CH-HB2-2018 strain and expressed it in HEK-293 F cells. Following alpaca immunization with the purified S protein, a phage display library was constructed. Biopanning yielded 70 unique Nbs based on CDR diversity, with 67 confirmed as specific binders via ELISA and Western blot. Further characterization using immunofluorescence and flow cytometry identified 9 specific candidates. Microneutralization assays revealed that these candidates showed varying degrees of inhibition against PEDV replication in Vero cells. Notably, nanobody 3Nb17 exhibited the highest binding affinity and neutralizing titer. These findings highlight 3Nb17 as a promising candidate for developing novel PEDV diagnostic tools and therapeutics.